Results 61 to 70 of about 6,308 (185)

Unmasking Idiopathic Inflammatory Myopathy: A Case of Proximal Weakness in a Young Male With Co‐Occurring Vitamin D Deficiency

open access: yesClinical Case Reports, Volume 13, Issue 11, November 2025.
ABSTRACT Idiopathic inflammatory myopathy (IIM) encompasses rare autoimmune disorders causing muscle inflammation and weakness, with subtypes including dermatomyositis, necrotizing myopathy, antisynthetase syndrome, and inclusion body myositis. This case report details a 25‐year‐old South Asian male presenting with a 60‐day history of progressive ...
Ibrahim Khalil   +3 more
wiley   +1 more source

Chimeric Antigen Receptor T‐Cell Therapy and Autoimmune Diseases in the Nervous System

open access: yesImmunity, Inflammation and Disease, Volume 13, Issue 11, November 2025.
ABSTRACT Introduction Chimeric antigen receptor T‐cell (CAR‐T) therapy, a revolutionary immunotherapy originally developed for hematologic malignancies, has recently gained attention for its potential in treating autoimmune diseases. Increasing evidence suggests that CAR‐T cells can precisely target pathogenic immune populations, offering durable ...
Shun‐yu Yao   +11 more
wiley   +1 more source

The Role of C/EBP‐Homologous Protein in Idiopathic Inflammatory Myopathies

open access: yesJournal of Cellular and Molecular Medicine, Volume 29, Issue 21, November 2025.
ABSTRACT The Idiopathic Inflammatory Myopathies (IIMs) are a group of autoimmune disorders characterised by persistent muscle inflammation and diverse clinical manifestations. Common symptoms include muscle weakness, myalgia, and elevated serum creatine kinase levels. Recent findings highlight the relevance of muscle fibre necrosis in IIMs.
Monica Sciacco   +9 more
wiley   +1 more source

Dermatomyositis and Polymyositis: Are Both Ends of a Same Spectrum?

open access: yes
Journal of Cosmetic Dermatology, Volume 25, Issue 1, January 2026.
Yashdeep Singh Pathania
wiley   +1 more source

Pathophysiological Mechanisms and Treatment of Dermatomyositis and Immune Mediated Necrotizing Myopathies: A Focused Review [PDF]

open access: gold, 2022
Renske G Kamperman   +4 more
openalex   +1 more source

Immune-mediated necrotizing myopathy [PDF]

open access: yesNeurologie pro praxi, 2017
Tomáš Kalous, Josef Zámečník
openaire   +1 more source

Immune-mediated necrotizing myopathy due to statins exposure.

open access: yesActa myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology, 2018
Statin-induced necrotizing autoimmune myopathy (IMNM) is an autoimmune disorder induced by anti-3-hydroxy-3-methylglutaryl-coenzyme-A reductase (anti-HMGCR) antibodies. We performed a retrospective clinical, histological, and radiological evaluation of 5 patients with a 3-year therapeutic follow-up.
Villa, Luisa   +11 more
openaire   +2 more sources

Immune-Mediated Necrotizing Myopathy Initially Presenting as Erythema Nodosum.

open access: yesJournal of inflammation research, 2020
Immune-mediated necrotizing myopathy (IMNM) is a type of autoimmune myopathy characterized by severe diffuse proximal myofiber necrosis in the context of inflammatory myopathy. Autoantibodies of anti-signal recognition particle and anti-hydroxy-3-methylglutaryl-CoA reductase are two antibodies specific to IMNM.
Ying,Shuni   +8 more
openaire   +4 more sources

Immune-mediated necrotizing myopathy: an important differential diagnosis of muscle weakness

open access: bronze, 2021
Camila Aguiar Lomônaco   +4 more
openalex   +1 more source

Home - About - Disclaimer - Privacy